M. Nedeljković
Oncology · with Damjanović · 2019
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 18 citations into it
Whom M. Nedeljković trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from M. Nedeljković's perspective
Ordered by how strongly the researchers M. Nedeljković trusts endorse each paper. Same corpus, a different order for every researcher.
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications (Proceedings of the National Academy of Sciences of the United States of America)
- Molecular portraits of human breast tumours (Nature)
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. (Journal of Clinical Investigation)
- Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. (Journal of Clinical Oncology)
- Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence (Clinical Cancer Research)
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation (New England Journal of Medicine)
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (Ca)
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features (Proceedings of the National Academy of Sciences of the United States of America)
- Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. (Cancer Research)
- A randomised phase III trial of carboplatin compared with docetaxel in BRCA1/2 mutated and pre-specified triple negative breast cancer “BRCAness” subgroups: the TNT Trial (Nature Medicine)